No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection.

Andrea LaurenziAmelia CarettoChiara MolinariAlessia MercalliRaffaella MelziRita NanoCristina TresoldiPatrizia Rovere Querini Fabio CiceriVito LampasonaEmanuele BosiMarina Scavini Lorenzo Piemonti

Published in: The Journal of clinical endocrinology and metabolism (2021)

COVID-19 associated dysglycaemia is unlikely to become a lasting public health problem. Alarmist claims on the diabetes risk after COVID-19 pneumonia should be interpreted with caution.

Keyphrases

coronavirus disease
public health
sars cov
respiratory syndrome coronavirus
type diabetes
cardiovascular disease
health insurance
glycemic control
skeletal muscle
global health
extracorporeal membrane oxygenation
respiratory failure